Brand drug lobbyists are worried by signals that the Obama administration is preparing its own drug-price containment plan. Lobbyists, including one from outside the drug industry who has spoken to government officials, said the administration is researching what it can do without Congress, which would distinguish the plan from those recently circulated by Democratic presidential contenders Hillary Clinton and Sen. Bernie Sanders (I-VT) that require significant, and unlikely, acts of Congress. Despite the long-running rumors of an administration proposal, lobbyists...
You've followed a link to an article or document on InsideHealthPolicy.com.
There are two ways you can access this content.
Subscriber Login
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Sign up for a trial subscription.